Isoform Oncology Ltd
- Company number
- 16014187
- Status
- Active
- Type
- Private Limited Company
- Incorporated
- 12 Oct 2024
- Nature of business
- Research and experimental development on biotechnology
Registered office
Officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| SYED, Emilie Claudine Jennifer | Director | 30 May 2025 |
Control
| Name | Nature of control | Notified | Ceased |
|---|---|---|---|
| Dr Sarah Louise Morgan | Ownership Of Shares 25 To 50 Percent Voting Rights 25 To 50 Percent Right To Appoint And Remove Directors |
12 Oct 2024 | |
| Dr Lee Douglas Larcombe | Ownership Of Shares 25 To 50 Percent Voting Rights 25 To 50 Percent Right To Appoint And Remove Directors |
12 Oct 2024 |
Accounts
| Year ended | Net assets | Employees |
|---|---|---|
| 31 Oct 2025 | £192,964 | 3 |
Connections
Directors’ other companies
- SYED, Emilie Claudine Jennifer, Dr - Director at Migration Biotherapeutics Limited
- SYED, Emilie Claudine Jennifer, Dr - Director at Cellestial Health Ltd
- SYED, Emilie Claudine Jennifer, Dr - Director at Bioharv Ltd
- SYED, Emilie Claudine Jennifer, Dr - Director at Sycamore Property Limited
Companies at the same address
- Applied Exomics Ltd (08251827)
- Artemida Pharma Limited (09004411)
- Autifony Alpha Limited (11924528)
- Autifony Therapeutics Limited (07543962)
- Awridian Ltd (07798594)
- Bioa3 Ltd (16700091)
- Biores Ltd (16349656)
- Cerebro Cmc Limited (10876137)
- Hubro Bioscience Ltd (16824289)
- Microfluidx Ltd (11643516)